GOLDENSEAL(HYDRASTIS CANADENSIS)REMEDY FOR ORAL DISEASES
金印(加拿大水螅)治疗口腔疾病
基本信息
- 批准号:6226269
- 负责人:
- 金额:$ 17.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-15 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (APPLICANT'S ABSTRACT): Complementary and alternative medicine
(CAM) has recently gained popularity with the American public. Research
validating CAM has focused mainly on the treatment and prevention of systemic
medical diseases while less attention has been paid to oral diseases. Oral
diseases including dental caries and periodontal disease, are a major cause of
loss of work and school days. Chemical and mechanical means have been used to
control dental plaque bacteria, the etiologic agent of caries and periodontal
disease. However, none of the available agents is ideal and frequently cause
adverse effects. This justifies further search and development of alternative
agents from natural sources that are safe and effective.
The North American plant, Hydrastis canadensis L. (Ranunculaceae), known
commercially as "Goldenseal," has been used for centuries as an antiseptic to
treat skin disorders and as an antidiarrheal, antiseptic, astringent,
hemostatic, and vasoconstrictor agent. Goldenseal is one of the major
phytomedicines ("herbal remedies") sold in health food stores and pharmacies in
the U.S. Several mouthrinses and toothpastes containing Goldenseal are
available on the market. Although claims have been made by the manufactures
regarding its ability to fight gum diseases and prevent caries, no scientific
data is available to substantiate these claims. The goal of the proposed
research is to evaluate the potential of Goldenseal as a remedy in prevention
and treatment of oral diseases and to maintain oral health. It is hypothesized
that antimicrobial compounds that are safe for humans can be identified from H.
canadensis. These compounds may have potential as dental
prophylactic/therapeutic agents and may also serve as lead compounds for the
subsequent design and synthesis of new agents that are even more effective than
the existing ones. The Specific Aims of this study are: SA1: To isolate and
identify active antimicrobial compounds from H. canadensis by activity-guided
fractionation and characterization; SA2: To determine antimicrobial activity of
the purified compounds against cariogenic and periodontal pathogens; SA3: To
investigate mixtures of purified antimicrobial compounds from H. canadensis for
synergistic antimicrobial activities; SA4: To correlate bioactivity of various
commercially available Goldenseal-containing oral hygiene products with levels
of active alkaloids identified in SA2.
The proposed research is innovative in that it represents collaboration between
an oral microbiologist and a natural product chemist that will assure the
speedy discovery of novel or known active compounds from Goldenseal and will
provide scientific explanation as to the remedy's efficacy. It will also serve
as a model system for the evaluation of existing herbal remedies for their oral
health related claims. This application of CAM research will help to achieve
better oral health and oral disease prevention, one of the to priority areas of
focus specified b the U.S. Public Health Service in "Health People 2000."
描述(申请人的摘要):补充和替代药物
(CAM)最近在美国公众中广受欢迎。研究
验证CAM主要集中于全身治疗和预防
医疗疾病虽然对口腔疾病的关注较少。口服
包括龋齿和牙周疾病在内的疾病是
失去工作和上学的日子。化学和机械手段已用于
对照牙菌斑细菌,龋齿和牙周的病因学剂
疾病。但是,没有一个可用的代理人是理想的,并且经常引起
不利影响。这证明了替代方案的进一步搜索和发展
来自自然来源的代理商安全有效。
北美植物,Hydrastis Canadensis L.(Ranunculaceae),已知
在商业上作为“戈德米”已被用作数百年来
治疗皮肤疾病,并作为抗动脉,防腐剂,与收敛剂
止血和血管收缩剂。金esheal是主要的
植物医学(“草药疗法”)在保健食品商店和药房中出售
美国几个嘴骨和牙膏含有金eseal
在市场上可用。尽管制造商已经提出了索赔
关于它与牙龈疾病和预防龋齿的能力,没有科学
数据可用于证实这些主张。提议的目标
研究是为了评估黄金化作为预防补救措施的潜力
和口腔疾病的治疗并维持口腔健康。它是假设的
可以从H中鉴定出对人类安全的抗菌化合物。
加拿大。这些化合物可能具有牙齿的潜力
预防性/治疗剂,也可以用作铅化合物
随后的设计和合成的新代理人比
现有的。这项研究的具体目的是:SA1:隔离和
通过活性引导,鉴定来自加拿大h。H.canadensis的活性抗菌化合物
分馏和表征; SA2:确定抗菌活性
纯化的化合物针对牙科和牙周病原体; SA3:到
研究纯化的抗菌化合物的混合物
协同抗菌活性; SA4:与各种生物活性相关
具有水平的市售的含戈金斯的口腔卫生产品
在SA2中鉴定的活性生物碱。
拟议的研究具有创新性,因为它代表
口服微生物学家和天然产品化学家,将确保
快速发现戈尔卡利的新颖或已知活性化合物,并将
就补救措施的功效提供科学解释。它也将服务
作为评估其口服现有草药疗法的模型系统
与健康有关的主张。这种CAM研究的应用将有助于实现
更好的口腔健康和预防口腔疾病,这是优先领域之一
重点指定的B美国公共卫生服务在“健康人2000”中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine D Wu其他文献
A preliminary survey of interprofessional education.
跨专业教育的初步调查。
- DOI:
- 发表时间:
2006 - 期刊:
- 影响因子:2.3
- 作者:
M. Rafter;I. Pesun;M. Herren;Jeffrey Linfante;M. Mina;Christine D Wu;J. P. Casada - 通讯作者:
J. P. Casada
Christine D Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine D Wu', 18)}}的其他基金
Blueprints for Transforming Research at UIC College of Dentistry
UIC 牙科学院研究转型蓝图
- 批准号:
6695692 - 财政年份:2003
- 资助金额:
$ 17.34万 - 项目类别:
GOLDENSEAL(HYDRASTIS CANADENSIS)REMEDY FOR ORAL DISEASES
金印(加拿大水螅)治疗口腔疾病
- 批准号:
6516648 - 财政年份:2001
- 资助金额:
$ 17.34万 - 项目类别:
GLUCAN-INDUCED AGGLUTINATION/VIRULENCE OF STREPTOCOCCUS
葡聚糖诱导的链球菌凝集/毒力
- 批准号:
3222333 - 财政年份:1990
- 资助金额:
$ 17.34万 - 项目类别:
GLUCAN-INDUCED AGGLUTINATION/VIRULENCE OF STREPTOCOCCUS
葡聚糖诱导的链球菌凝集/毒力
- 批准号:
3222334 - 财政年份:1990
- 资助金额:
$ 17.34万 - 项目类别:
GLUCAN-INDUCED AGGLUTINATION/VIRULENCE OF STREPTOCOCCUS
葡聚糖诱导的链球菌凝集/毒力
- 批准号:
3222331 - 财政年份:1990
- 资助金额:
$ 17.34万 - 项目类别:
GLUCAN-INDUCED AGGLUTINATION/VIRULENCE OF STREPTOCOCCUS
葡聚糖诱导的链球菌凝集/毒力
- 批准号:
3222332 - 财政年份:1990
- 资助金额:
$ 17.34万 - 项目类别:
GLUCAN-INDUCED AGGLUTINATION/VIRULENCE OF STREPTOCOCCUS
葡聚糖诱导的链球菌凝集/毒力
- 批准号:
3222330 - 财政年份:1989
- 资助金额:
$ 17.34万 - 项目类别:
相似国自然基金
结合态抗生素在水产品加工过程中的消解机制与产物毒性解析
- 批准号:32302247
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于Fe-N-BC/PMS体系的自由基与非自由基协同降解地下水中磺胺类抗生素的机制研究
- 批准号:42377036
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于高通量测序和培养组学的伴侣动物-人抗生素抗性基因分布特征及传播研究
- 批准号:82373646
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
微藻-细菌协同降解抗生素及其共适应机制
- 批准号:42377367
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
多环芳烃影响大肠杆菌抗生素耐药性进化的分子机制
- 批准号:32301424
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
- 批准号:
10653587 - 财政年份:2023
- 资助金额:
$ 17.34万 - 项目类别:
Determining the Efficacy of a Novel Apatite-Based Antimicrobial Bone Scaffold for Craniofacial Surgical Applications
确定新型磷灰石抗菌骨支架在颅面外科应用中的功效
- 批准号:
10573777 - 财政年份:2023
- 资助金额:
$ 17.34万 - 项目类别:
Repurposing Styrene Catabolic Enzymes for the Synthesis of Penicillins
重新利用苯乙烯分解代谢酶来合成青霉素
- 批准号:
10686815 - 财政年份:2022
- 资助金额:
$ 17.34万 - 项目类别:
Development of DksA-targeted Antibiotics for Treatment of Gram-negative Infections
开发用于治疗革兰氏阴性菌感染的 DksA 靶向抗生素
- 批准号:
10487785 - 财政年份:2022
- 资助金额:
$ 17.34万 - 项目类别:
VLP-based Vaccines for Targeting Staphylococcus Aureus β-barrel Toxins
基于 VLP 的针对金黄色葡萄球菌 β 桶毒素的疫苗
- 批准号:
10538909 - 财政年份:2022
- 资助金额:
$ 17.34万 - 项目类别: